Share Consolidation Update
IM Cannabis common shares commence trading on a 30:1 consolidated basis on Nasdaq.
Anonymous
IM Cannabis Corp. (IMC) started trading on the Nasdaq Capital Market on a new, consolidated basis on August 30, 2026. The company combined every 30 old shares into 1 new share, cutting the total from 18.6 million shares down to about 618,900. Yahoo Finance confirmed the move aims to bring the stock in line with Nasdaq listing standards.
Shareholders who own shares directly received letters from Computershare, the transfer agent, with instructions on how to exchange their old certificates for new ones. Investors who hold shares through brokers don't need to do anything—their accounts will update automatically. The consolidation, called a reverse split, is a common move when companies want to raise their share price.
How the Share Consolidation Works
IM Cannabis combined shares at a 30-to-1 ratio, meaning every 30 old shares became 1 new share. Barchart reported the share count dropped from 18,567,650 to 618,899 after rounding adjustments. This type of consolidation is used to increase the per-share price without changing what the company is actually worth.
Registered shareholders received official letters from Computershare with transmittal forms. These forms tell shareholders how to exchange old share certificates or electronic statements for new post-consolidation shares. The process protects investors by ensuring a clear record of the exchange.
What Beneficial Shareholders Need to Know
Most investors hold shares through brokers or banks rather than owning certificates directly. For these beneficial shareholders, no action is required. Their brokerages will handle the consolidation automatically, and share counts will update in their accounts without any effort on their part.
Anyone confused about how the consolidation affects their account should contact their broker or financial intermediary directly. Brokers have teams ready to explain how the new share count impacts holdings and answer questions about the process.
IM Cannabis and Its Market Position
IM Cannabis is a medical cannabis company with operations in Israel and Germany, PR Newswire noted. The consolidation reflects the company's effort to meet Nasdaq Capital Market listing requirements and maintain its trading status on the exchange.
Sentiment
NeutralNEGATIVENEUTRALPOSITIVE
Publishers
4
Articles
3
Reach
4
A
AnonymousAuthor
